Protalix BioTherapeutics posts February 2026 corporate presentation to website; no material new data disclosed

Protalix BioTherapeutics, Inc.

Company filed Form 8-K indicating a corporate presentation was posted on February 11, 2026.
Exhibit 99.1 consists solely of a title slide with no specific financial or pipeline updates.
No new guidance, clinical data, or business developments were provided in the furnished exhibit.
Investors would need to access the full presentation on the company website for details.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.